Share

June 16, 2009; 72 (24) Articles

The risks and costs of multiple-generic substitution of topiramate

M. S. Duh, P. E. Paradis, D. Latrémouille-Viau, P. E. Greenberg, S. P. Lee, M. B. Durkin, G. J. Wan, M.F.T. Rupnow, J. LeLorier
First published June 15, 2009, DOI: https://doi.org/10.1212/WNL.0b013e3181aa5300
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
799

Share

Article Information

vol. 72 no. 24 2122-2129
DOI: 
https://doi.org/10.1212/WNL.0b013e3181aa5300
PubMed: 
19528520
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published June 15, 2009.
Copyright & Usage: 
© 2009

Author Disclosures

    1. M. S. Duh, MPH, ScD,
    2. P. E. Paradis, MA, DESS,
    3. D. Latrémouille-Viau, MA,
    4. P. E. Greenberg, MS, MA,
    5. S. P. Lee, PharmD, MS,
    6. M. B. Durkin, MS,
    7. G. J. Wan, PhD, MPH,
    8. M.F.T. Rupnow, PhD and
    9. J. LeLorier, MD, PhD
  1. M. S. Duh, MPH, ScD,
  2. P. E. Paradis, MA, DESS,
  3. D. Latrémouille-Viau, MA,
  4. P. E. Greenberg, MS, MA,
  5. S. P. Lee, PharmD, MS,
  6. M. B. Durkin, MS,
  7. G. J. Wan, PhD, MPH,
  8. M.F.T. Rupnow, PhD and
  9. J. LeLorier, MD, PhD
  1. From the Analysis Group, Inc. (M.S.D., P.E.G.), Boston, MA; Groupe d'Analyse, Ltée (P.E.P., D.L.-V.), Montréal, Québec, Canada; Johnson & Johnson Pharmaceutical Services (S.P.L.), LLC, Horsham, PA; Ortho-McNeil Janssen Scientific Affairs (M.B.D., G.J.W.), LLC, Titusville, NJ; Ethicon, Inc. (M.F.T.R.), Somerville, NJ; and Centre Hospitalier de l'Université de Montréal (CHUM) (J.L.), Montréal, Québec, Canada.
  1. Address correspondence and reprint requests to Dr. Mei Sheng Duh, Vice President, Analysis Group, Inc., 111 Huntington Avenue, Tenth Floor, Boston, MA 02199 mduh{at}analysisgroup.com.
View Full Text

Article usage

Article usage: June 2009 to December 2022

AbstractFullPdfSource
Jun 200942796159Highwire
Jul 20091864272Highwire
Aug 20091473843Highwire
Sep 20091642639Highwire
Oct 20091211025Highwire
Nov 2009187924Highwire
Dec 20097639Highwire
Jan 2010103711Highwire
Feb 20101401024Highwire
Mar 2010901120Highwire
Apr 2010761821Highwire
May 20105637Highwire
Jun 201060511Highwire
Jul 20104845Highwire
Aug 20105348Highwire
Sep 20104967Highwire
Oct 20104139Highwire
Nov 20101702Highwire
Dec 20104423Highwire
Jan 201157108Highwire
Feb 20114374Highwire
Mar 20117078Highwire
Apr 20116256Highwire
May 20114646Highwire
Jun 20114657Highwire
Jul 20112822Highwire
Aug 20114113Highwire
Sep 20114836Highwire
Oct 20113800Highwire
Nov 20112501Highwire
Dec 20115500Highwire
Jan 20123212Highwire
Feb 20124122Highwire
Mar 20123331Highwire
Apr 20124835Highwire
May 20124335Highwire
Jun 20123612Highwire
Jul 20123623Highwire
Aug 20123703Highwire
Sep 20123122Highwire
Oct 20124212Highwire
Nov 20124548Highwire
Dec 20122134Highwire
Jan 20135221Highwire
Feb 20135587Highwire
Mar 20134831Highwire
Apr 20135411Highwire
May 20132633Highwire
Jun 20133812Highwire
Jul 20133243Highwire
Aug 20131900Highwire
Sep 20132100Highwire
Oct 20131923Highwire
Nov 20132433Highwire
Dec 20131523Highwire
Jan 20142311Highwire
Feb 20141502Highwire
Mar 20143001Highwire
Apr 20142132Highwire
May 20143834Highwire
Jun 20142011Highwire
Jul 20143233Highwire
Aug 20141111Highwire
Sep 20144401Highwire
Oct 20143313Highwire
Nov 20141710Highwire
Dec 20142411Highwire
Jan 20152557Highwire
Feb 20157537Highwire
Mar 20151400Highwire
Apr 20151600Highwire
May 2015911Highwire
Jun 20152121Highwire
Jul 20151100Highwire
Aug 20151811Highwire
Sep 20151101Highwire
Oct 20151602Highwire
Nov 20152112Highwire
Dec 20153401Highwire
Jan 20162000Highwire
Feb 20161800Highwire
Mar 20162322Highwire
Apr 2016601Highwire
May 20161820Highwire
Jun 20161510Highwire
Jul 20161400Highwire
Aug 20161911Highwire
Sep 20161800Highwire
Oct 20161300Highwire
Nov 20162012Highwire
Dec 20161200Highwire
Jan 20172100Highwire
Feb 20171400Highwire
Mar 20171733Highwire
Apr 20171911Highwire
May 20172100Highwire
Jun 20171100Highwire
Jul 20171000Highwire
Aug 2017922Highwire
Sep 2017800Highwire
Oct 20171700Highwire
Nov 2017901Highwire
Dec 20172212Highwire
Jan 20181121Highwire
Feb 20182617Highwire
Mar 20182701Highwire
Apr 2018601Highwire
May 20181833Highwire
Jun 20181501Highwire
Jul 20181422Highwire
Aug 20181923Highwire
Sep 20181123Highwire
Oct 20182911Highwire
Nov 20181400Highwire
Dec 20181411Highwire
Jan 201915202Highwire
Feb 20192311Highwire
Mar 20191621Highwire
Apr 20193400Highwire
May 20192200Highwire
Jun 20191111Highwire
Jul 20191100Highwire
Aug 20191031Highwire
Sep 20191422Highwire
Oct 20192411Highwire
Nov 20192321Highwire
Dec 20191500Highwire
Jan 20203310Highwire
Feb 2020910Highwire
Mar 2020600Highwire
Apr 20202001Highwire
May 20202221Highwire
Jun 20203812Highwire
Jul 2020800Highwire
Aug 20201411Highwire
Sep 2020910Highwire
Oct 20201501Highwire
Nov 20201342Highwire
Dec 20202411Highwire
Jan 2021286Highwire
Feb 20212122Highwire
Mar 20213386Highwire
Apr 20211276Highwire
May 2021932Highwire
Jun 20212155Highwire
Jul 20213611Highwire
Aug 20212222Highwire
Sep 20212020Highwire
Oct 20214212Highwire
Nov 20214011Highwire
Dec 20211900Highwire
Jan 20222211Highwire
Feb 20222500Highwire
Mar 20221777Highwire
Apr 2022231010Highwire
May 20222867Highwire
Jun 20221601Highwire
Jul 2022823Highwire
Aug 20222132Highwire
Sep 20221977Highwire
Oct 20222898Highwire
Nov 20223131Highwire
Dec 20224122Highwire

Cited By...

Letters: Rapid online correspondence

  • The risks and costs of multiple-generic substitution of topiramate
    • Nitin K. Sethi, New York-Presbyterian Hospital, Weill Cornell Medical Center, 525 East 68th Street, New York, NY 10065
    • Josh Torgovnick, Prahlad K. Sethi, and Edward Arsura
    Submitted August 18, 2009
  • Reply from the authors
    • Pierre Emmanuel Paradis, Analysis Group, Inc, Boston, MA 02199
    • M. S. Duh (Analysis Group, Inc, Boston, MA) M. B. Durkin, G. J. Wan (Ortho-McNeil Janssen Scientific Affairs, Titusville, NJ)
    Submitted August 18, 2009
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

More Online

CME Course

Topics Discussed

Alert Me